Key facts
- This page summarizes Patrick Rudolf Aghanian's Form 3 filing for DR REDDYS LABORATORIES LTD (RDY).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2026, 13:05.
Patrick Rudolf Aghanian - 18 Dec 2025 Form 3 Insider Report for DR REDDYS LABORATORIES LTD (RDY)
- Reporting relationship
- Head - Europe Generics
- Issuer ticker
- RDY
- Reported as of
- 18 Dec 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ PATRICK AGHNIAN
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Patrick Rudolf Aghanian filed Form 3 for DR REDDYS LABORATORIES LTD (RDY) on 01 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002125152
Primary reporting owner
AGHANIAN PATRICK RUDOLF
- Relationship
- Head - Europe Generics
- Address
- SEESTRASSE 59, 8002, ZURICH, SWITZERLAND
- Signature
- /s/ PATRICK AGHNIAN
- Signature date
- 01 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RDY
holding
Equity Shares underlying ADRs
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,450
- Date
- 18 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.